Wall Street Ends Lower as AI Stocks Drag Markets, Fed Rate Outlook Shifts 
Micron Stock Surges on Strong AI Demand, Record Revenue, and Bullish Q4 Forecast 
Gold Prices Rise Above $4,000 as Inflation Data and Weaker Dollar Boost Demand 
Trump Threatens 100% Tariffs on Countries Imposing Digital Services Taxes on U.S. Tech Firms 
SpaceX Stock Rebounds After Sharp Selloff, But Valuation Concerns Persist 
U.S. Dollar Reaches One-Year High as Tech Sell-Off and Fed Rate Hike Expectations Support Demand 
Trump Reportedly Approves Plan to Remove FDA Commissioner Marty Makary Amid Growing Controversies 
Trump Orders DOJ Investigation Into Exxon, Chevron Over High Gas Prices 
SpaceX Eyes Starlink Mobile Phone Service to Challenge Verizon, AT&T, and T-Mobile 
Australian Household Spending Rebounds Strongly in May as Travel and Dining Drive Consumer Growth 
Pelosi Discloses Major Intel and Uber Call Option Purchases Worth Up to $6 Million 
Bain Capital Nears Deal for Majority Stake in Volkswagen Marine Engine Unit Everllence 
Tesla and NatPower Partner on $5 Billion Battery Storage Expansion in Europe 
S&P Affirms Brazil’s BB Credit Rating with Stable Outlook Amid Fiscal Challenges 
Bayer Wins Major U.S. Supreme Court Roundup Lawsuit, Shares Surge 
Fortescue Faces Class Action Over Sexual Harassment Claims at Australian Mining Sites 
Organon Stock Surges After Reports of $13 Billion Buyout Bid by Sun Pharma 
Lotte Biologics Co. will invest $48 million into its Syracuse, New York, plant to upgrade and boost its production capacity for drugs and antibody-drug conjugates.
The South Korean company purchased the factory from Bristol Myers Squibb for $160 million last year as part of its strategy to go overseas.
Lotte Biologics will hire some 70 new workers as part of plans to expand its facilities.
The Syracuse plant can annually produce 35,000 liters of drug substances.
Lotte Biologics has been beefing up its production capacity and plans to invest $3 billion to build a bio-industrial complex in South Korea by 2030, to post $3 billion in revenue.
